Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06931301 · ClinicalTrials.gov registry record · NA
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT06931301 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 400 participants.
The verdict
NCT06931301, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
Interventions
- DEVICE Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-12 |
| Est. Completion | 2035-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06931301
The ClinicalTrials.gov registry entry for NCT06931301 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT06931301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06931301 about?
NCT06931301 is a clinical study titled "Effect of HBOT on Femoral Head Avascular Necrosis (AVN)". The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
What is the current status of trial NCT06931301?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-12. Estimated completion is 2035-04.
What interventions are being tested in trial NCT06931301?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DEVICE).
Who is sponsoring clinical trial NCT06931301?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.